<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>Thermo Fisher Scientific Expands Neurodegeneration Research Capabilities with Launch of Olink® Target 48 Neurodegeneration Panel — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Thermo Fisher Scientific Expands Neurodegeneration Research Capabilities with Launch of Olink® Target 48 Neurodegeneration Panel</h2>
    <div class="badge">2025-09-15T20:15:00+00:00</div>
    <ul>
      <li>Thermo Fisher Scientific Expands Neurodegeneration Research Capabilities with Launch of Olink® Target 48 Neurodegeneration Panel Targeted proteomics panel delivers absolute quantification of key and emerging biomarkers i</li>
<li>The Target 48 Neurodegeneration panel is the latest addition to Olink’s growing portfolio of multiplex disease panels with absolute quantification readouts.</li>
<li>Alongside the Olink® Target 48 Cytokine, Olink® Target 48 Immune Surveillance, and the semi-custom Olink® Flex platform, this solution helps create a powerful ecosystem for proteomics research.</li>
<li>This panel delivers simultaneous measurement of 41 key and emerging proteins for neurodegeneration research with absolute quantification and optimized for plasma measurement from as little as 1µL of sample.</li>
<li>&quot;The panel, designed in close collaboration with leading clinical researchers, offers absolute quantification of multiplex key biomarkers to monitor disease progression and therapeutic responses to power precision medici</li>
<li>An early access user, Charlotte Teunissen, professor in neurochemistry at the Department of Laboratory Medicine at Amsterdam University Medical Center, shared, &quot;The Target 48 Neurodegeneration panel is a critical tool th</li>
<li>With diseases such as Alzheimer’s, multiple sclerosis and Parkinson’s on the rise and clinical pipelines eager for translational biomarkers, researchers face a pressing need for scalable, reproducible and disease-relevan</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=Thermo Fisher Scientific Expands Neurodegeneration Research Capabilities with Launch of Olink® Target 48 Neurodegeneration Panel\n• Thermo Fisher Scientific Expands Neurodegeneration Research Capabilities with Launch of Olink® Target 48 Neurodegeneration Panel Targeted proteomics panel delivers absolute quantification of key and emerging biomarkers i\n• The Target 48 Neurodegeneration panel is the latest addition to Olink’s growing portfolio of multiplex disease panels with absolute quantification readouts.\n• Alongside the Olink® Target 48 Cytokine, Olink® Target 48 Immune Surveillance, and the semi-custom Olink® Flex platform, this solution helps create a powerful ecosystem for proteomics research.\n• This panel delivers simultaneous measurement of 41 key and emerging proteins for neurodegeneration research with absolute quantification and optimized for plasma measurement from as little as 1µL of sample.\n• &quot;The panel, designed in close collaboration with leading clinical researchers, offers absolute quantification of multiplex key biomarkers to monitor disease progression and therapeutic responses to power precision medici\n• An early access user, Charlotte Teunissen, professor in neurochemistry at the Department of Laboratory Medicine at Amsterdam University Medical Center, shared, &quot;The Target 48 Neurodegeneration panel is a critical tool th\n• With diseases such as Alzheimer’s, multiple sclerosis and Parkinson’s on the rise and clinical pipelines eager for translational biomarkers, researchers face a pressing need for scalable, reproducible and disease-relevan" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/news/thermo-fisher-scientific-expands-neurodegeneration-201500392.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>